IM Cannabis regains compliance with Nasdaq’s minimum bid price requirement

  • Medical cannabis company IM Cannabis (NASDAQ:IMCC) said on Tuesday that it has received a Nasdaq notice on having regained compliance with the stock exchange’s minimum bid price requirement.
  • The company was notified of non-compliance on April 10 with Nasdaq’s minimum bid price requirement of $1.00 per share for 30 consecutive business days from Feb. 24 to April 6.
  • Source: Press Release

Now read: Akebia Therapeutics announces new finance chief

Author: CSN